Physician profile
Breil J Schutz
NPI 1972914026
$3,199.62
in general payments reported to CMS, 2019-2025
17 companies · $1,362 in 2025
The $1,362 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.85 · 2022: $38.71 · 2023: $581 · 2024: $1,157 · 2025: $1,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,100.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $927.70 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $628.62 | 2023-2025 | Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $375.96 | 2023-2025 | Belbuca, Xtampza |
| Radius Health, INC. | $211.00 | 2023-2025 | Tymlos |
| Spinal Simplicity, LLC | $208.41 | 2024 | Ha Minuteman G3-R |
| Pfizer INC. | $188.61 | 2025 | |
| Nalu Medical, INC. | $148.83 | 2025 | Nalu Neurostimulation System |
| Curonix LLC | $147.46 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $139.80 | 2025 | Omnia |
| Sunovion Pharmaceuticals INC. | $65.75 | 2021-2022 | |
| Uswm, LLC | $33.81 | 2021 | |
| Antares Pharma, INC. | $31.58 | 2024 | Xyosted |
| Halozyme INC | $20.34 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $20.12 | 2025 | |
| Tonix Medicines, INC. | $18.01 | 2025 | Tonmya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.76 | 2024 | Evenity |
| Lilly USA, LLC | $15.86 | 2023 | Emgality, Reyvow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breil Schutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.